BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FAS, FAS1, 355, ENSG00000026103, FASTM, APO-1, P25445, CD95, ALPS1A, TNFRSF6, APT1 AND Prognosis
101 results:

  • 1. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
    Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
    Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. TMEM120B strengthens breast cancer cell stemness and accelerates chemotherapy resistance via β1-integrin/FAK-TAZ-mTOR signaling axis by binding to MYH9.
    Hu R; Cao Y; Wang Y; Zhao T; Yang K; Fan M; Guan M; Hou Y; Ying J; Ma X; Deng N; Sun X; Zhang Y; Zhang X
    Breast Cancer Res; 2024 Mar; 26(1):48. PubMed ID: 38504374
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Age-related phenotypes in breast cancer: A population-based study.
    Svanøe AA; Humlevik ROC; Knutsvik G; Sæle AKM; Askeland C; Ingebriktsen LM; Hugaas U; Kvamme AB; Tegnander AF; Krüger K; Davidsen B; Hoivik EA; Aas T; Stefansson IM; Akslen LA; Wik E
    Int J Cancer; 2024 Jun; 154(11):2014-2024. PubMed ID: 38319154
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeting breast cancer with N-Acetyl-D-Glucosamine: Integrating Machine Learning and Cellular Assays for Promising Results.
    Baysal Ö; Genç D; Silme RS; Kırboğa KK; Çoban D; Ghafoor NA; Tekin L; Bulut O
    Anticancer Agents Med Chem; 2024; 24(5):334-347. PubMed ID: 38305389
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cd95 promotes stemness of colorectal cancer cells by lncRNA MALAT1.
    Gao C; Jia K; Fang J; Zhu X; Hu J; Zhang Y; Jiang J; Yu X; Wang D; Gu H; Chen Z
    Life Sci; 2024 Feb; 338():122394. PubMed ID: 38159593
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Tubular Adenoma of the breast: Radiologic-Pathologic Correlation.
    Joo GJ; Carter GJ; Berg WA
    J Breast Imaging; 2023 Nov; 5(6):703-711. PubMed ID: 38141235
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. AIRE is expressed in breast cancer TANs and TAMs to regulate the extrinsic apoptotic pathway and inflammation.
    Källberg E; Mehmeti-Ajradini M; Björk Gunnarsdottir F; Göransson M; Bergenfelz C; Allaoui Fredriksson R; Hagerling C; Johansson ME; Welinder C; Jirström K; Leandersson K
    J Leukoc Biol; 2024 Mar; 115(4):664-678. PubMed ID: 38060995
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of immune checkpoint inhibition in triple negative breast cancer.
    Tarekegn K; Keskinkilic M; Kristoff TJ; Evans ST; Kalinsky K
    Expert Rev Anticancer Ther; 2023; 23(10):1095-1106. PubMed ID: 37771270
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
    Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
    Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1.
    Xu C; Yang K; Xuan Z; Li J; Liu Y; Zhao Y; Zheng Z; Bai Y; Shi Z; Shao C; Zhang L; Sun H
    Cell Death Dis; 2023 Jul; 14(7):445. PubMed ID: 37460470
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hypoxia-induced YAP activation and focal adhesion turnover to promote cell migration in mesenchymal TNBC cells.
    Nguyen TMH; Lai YS; Chen YC; Lin TC; Nguyen NT; Chiu WT
    Cancer Med; 2023 Apr; 12(8):9723-9737. PubMed ID: 36757143
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The FOXO1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
    Flores D; Lopez A; Udawant S; Gunn B; Keniry M
    FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MARCKS as a Potential Therapeutic Target in Inflammatory breast cancer.
    Manai M; ELBini-Dhouib I; Finetti P; Bichiou H; Reduzzi C; Aissaoui D; Ben-Hamida N; Agavnian E; Srairi-Abid N; Lopez M; Amri F; Guizani-Tabbane L; Rahal K; Mrad K; Manai M; Birnbaum D; Mamessier E; Cristofanilli M; Boussen H; Kharrat M; Doghri R; Bertucci F
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139501
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Snail Mucus Enhances Chemosensitivity of Triple-negative breast cancer
    Ho CY; Hu DW; Chen BR; Yang CC; Yao CH; Ni T; Ho WC; Chen YS; Tu CY; Chang WC; Wu YC; Tang CH; Huang HC; Huang WC; Li TS
    Anticancer Res; 2022 Feb; 42(2):845-855. PubMed ID: 35093882
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Alpha1-antitrypsin combined fatty acids induced angiopoietin-like protein 4, expression in breast cancer: A pilot study.
    Preethika A; Suchetha Kumari N; Sandeep A; Shetty J
    Chem Phys Lipids; 2022 Mar; 243():105175. PubMed ID: 35063423
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Computer-assisted quantification of tumor-associated collagen signatures to improve the prognosis prediction of breast cancer.
    Xi G; Qiu L; Xu S; Guo W; Fu F; Kang D; Zheng L; He J; Zhang Q; Li L; Wang C; Chen J
    BMC Med; 2021 Nov; 19(1):273. PubMed ID: 34789257
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
    Quan J; Bode AM; Luo X
    Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. High fas expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer.
    Zhang Y; Shao X; Gao C; Xu D; Wu J; Zhu X; Chen Z
    Cancer Biomark; 2021; 32(2):207-219. PubMed ID: 34092611
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Selection of aptamers against triple negative breast cancer cells using high throughput sequencing.
    Ferreira D; Barbosa J; Sousa DA; Silva C; Melo LDR; Avci-Adali M; Wendel HP; Rodrigues LR
    Sci Rep; 2021 Apr; 11(1):8614. PubMed ID: 33883615
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.